Amineptine

NERVOUS SYSTEM

Key facts

Amineptine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including Slc6a3. Recorded indications include Depressive disorder.

• Molecular targets: Slc6a3 (1 listed in DrugCentral).
• Indications: Depressive disorder.
• ATC code: N06AA19 (Non-selective monoamine reuptake inhibitors).
• Molecular formula: C22H27NO2; molecular weight 337.46 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Depressive disorder

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Sodium-dependent dopamine transporter	Slc6a3	unknown	IC50 6.00

ATC classification

ATC code	Therapeutic hierarchy
N06AA19	NERVOUS SYSTEM › PSYCHOANALEPTICS › ANTIDEPRESSANTS › Non-selective monoamine reuptake inhibitors

Chemical structure

• Molecular formula: C₂₂H₂₇NO₂
• Molecular weight: 337.46 g/mol
• CAS number: 57574-09-1
• InChIKey: ONNOFKFOZAJDHT-UHFFFAOYSA-N
• PubChem CID: 34870

OC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Amineptine used for?

DrugCentral lists the following indications for Amineptine: Depressive disorder.

How does Amineptine work?

Its molecular targets in DrugCentral include Slc6a3.

What is the chemical formula of Amineptine?

Amineptine has the molecular formula C22H27NO2 and a molecular weight of 337.46 g/mol.

Sources

• DrugCentral drug card 161 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1697712 — compound record and bioactivity
• PubChem CID 34870 — chemical identifiers
• DrugBank DB04836 — drug record
• FDA UNII 27T1I13L6G — substance identity

How this page is built: methodology · editorial policy & corrections.